121 King Street, Melbourne [email protected]

development of validated disease activity and damage

development of validated disease activity and damage

(PDF) Development and initial validation of the Localized

The median (interquartile range) time to first recurrence of disease activity after initial resolution of disease activity was 1.1 (0.8-1.9) years for generalized subtype and 2.3 (1.0-3.3) years 12345NextCited by 13Publish Year 2018Author Nienke M.Ter Haar,Amber Laetitia Justine Van Delft,Kim Valerie Annink,Henk Van Stel,Sulaiman M.Development and preliminary validation of a paediatric Mar 01,2011·Objectives To develop and validate a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis (JIA).To compare the paediatric MRI score with the adult-designed.Outcome Measures in Rheumatology Clinical TrialsRheumatoid Arthritis MRI Score (RAMRIS),whose suitability for assessing growing joints was

Cited by 1Publish Year 2020Author Matteo Piga,Alberto Floris,Gerard Espinosa,Luísa Serpa Pinto,Nikolaos Kougkas,Andrea Lo Monaco,Development and content validity of the Lupus Foundation

Jun 07,2019·The LFA REAL is a measurement system for evaluating lupus disease activity from both clinician and patient perspectives.Patients viewpoints are captured using a patient-reported outcome (PRO) questionnaire.A series of visual analog scales are designed to rate disease severity and progress over the past 4 weeks.Brief instructions guide the patient to distinguish between active Cited by 1Publish Year 2020Author Matteo Piga,Alberto Floris,Gerard Espinosa,Luísa Serpa Pinto,Nikolaos Kougkas,Andrea Lo Monaco,Development and preliminary validation of a paediatric Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis.Malattia C(1),Damasio MB,Pistorio A,Ioseliani M,Vilca I,Valle M,Ruperto N,Viola S,Buoncompagni A,Cited by 250Publish Year 2004Author D.A.Isenberg,E.Allen,V.Farewell,M.R.Ehrenstein,M.G.Hanna,I.E.Lundberg,C.Oddis,C.PThe development of the disease activity score (DAS) and sociated with disease activity,and in late disease with joint damage (12).Using mixed models for longitudinal data analysis (13),patients who had a constant low disease activity over time had about half the progression of joint damage as patients who had constant high disease activity (Fig.1).Moreo-ver,fluctuating disease activity added

Cited by 282Publish Year 1999Author Daniel J.Lovell,Carol B.Lindsley,Robert M.Rennebohm,Susan H.Ballinger,Suzanne L.Bowyer,EdwDevelopment of validated disease activity and damage

·The effects of disease activity and damage,using validated metrics,on the outcomes of damage accrual [measured by the Systemic Lupus International Collaborating Clinics/American College of Rheuma- tology Damage Index (SDI)] and mortality were assessed.A list of candidate disease activity and damage measures was identified by the group through the American College ofCited by 4Publish Year 2019Author Philippe Mertz,Alexandre Belot,Ricard Cervera,Tyng Yu Chuah,Lorenzo Dagna,Laura Damian,DebashiDevelopment and Preliminary Validation of a New·Active SLE disease activity and damage are associated with and predict greater mortality.Image Credit ISM.In patients with systemic lupus erythematosus (SLE),disease activity and damage as measured by validated metrics are associated with increased mortality and damage accrual,according to the results of meta-analyses published in The Cited by 6Publish Year 2018Author Stephanie O.Keeling,Ben Vandermeer,Jorge Medina,Trish Chatterley,Tatiana Nevskaya,Tatiana NevsDevelopment and preliminary validation of the Behçets Jul 01,2020·Disease activity refers to reversible inflammatory manifestations that might resolve spontaneously or if adequately treated,whereas damage refers to irreversible manifestations that,once they have occurred,will not respond to treatment escalation.7 8 According to the Outcome Measures in Rheumatology (OMERACT) working group,both measures of disease activity and damage should be

Cited by 6Publish Year 2018Author Stephanie O.Keeling,Ben Vandermeer,Jorge Medina,Trish Chatterley,Tatiana Nevskaya,Tatiana NevsDevelopment of validated disease activity and damage

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies II.The childhood myositis assessment scale (CMAS) a quantitative tool for the evaluation of muscle function Development of validated disease activity and damage indices for the juvenile idiopathicCited by 72Publish Year 2011Author Clara Malattia,Maria Beatrice Damasio,Angela Pistorio,Maka Ioseliani,Iris Vilca,Maura Valle,NiDevelopment and preliminary validation of a paediatric Objectives To develop and validate a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis (JIA).To compare the paediatric MRI score with the adult-designed.Outcome Measures in Rheumatology Clinical Trials-Rheumatoid Arthritis MRI Score (RAMRIS),whose suitability for assessing growing joints was tested.Cited by 72Publish Year 2011Author Clara Malattia,Maria Beatrice Damasio,Angela Pistorio,Maka Ioseliani,Iris Vilca,Maura Valle,NiInternational consensus outcome measures for patients with Jul 16,2003·In the past 15 yr there have been several international attempts to define validated disease activity and damage indices to assess patients with systemic lupus erythematosus [reviewed in 1].These have been welcome developments following several decades during which some 60 disease activity indices,neither validated nor compared,had been

Cited by 72Publish Year 2011Author Clara Malattia,Maria Beatrice Damasio,Angela Pistorio,Maka Ioseliani,Iris Vilca,Maura Valle,NiOriginal research Development and preliminary

effectively measure damage (construct validity),but had greater sensitivity in identifying major organ damage and did not correlate with disease activity measures (ie,BDCAF p=0.807,PGA p=0.820,PtGA p=0.794) discriminating damage from the major confounding factor.The instrument was deemed credible (face validity),complete (contentDevelopment and content validity of the LupusDevelopment and content validity of the (SLAQ) is a validated disease activity PRO,de-rived from the SLAM,that has been validated and used disease from damage and depression.Development of validated disease activity and damage Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies.II.The Childhood Myositis Assessment Scale (CMAS) a quantitative tool for the evaluation of muscle function.The Juvenile Dermatomyositis Disease Activity Collaborative Study

In silico validation of the Autoinflammatory Disease

indices of disease activity).Continuously during development and validation of the ADDI,content validity,face validity and adherence to the OMERACT principles (truth,discrimination and feasibility) were assessed.1214 As a reference standard for disease damage in AIDs is lacking,criterion validity cannot be determined.Measuring Disease Activity and Damage with Validated Aug 15,2018·Objective To identify the effect of disease activity and damage,measured by validated indices,on mortality and damage accrual,in order to inform upcoming Canadian systemic lupus erythematosus (SLE) recommendations.Methods Following GRADE (Grading of Recommendations Assessment,Development and Evaluation) methodology to fill in evidence-to-decision tables toThe CLASI,a validated tool for the evaluation of skin the lack of focus on skin outcomes has led to the development of the Cutaneous Lupus Disease Area and Severity Index (CLASI),a validated organ-specific outcome measure that is not only responsive to change in disease activity and damage but also correlated to

The Disease Activity Score (DAS) and the Disease Activity

ces used to measure disease activity in RA (2,6,7).In long term studies with 9 years follow-up the relationship be-tween disease activity measured with the DAS,joint destruction and func-tional capacity was shown.In early RA,functional capacity was most as-sociated with disease activity,and in late disease with joint damage (8).TheThe relapsing polychondritis damage index (RPDAM May 01,2019·Notably,distinguishing between disease activity and damage is a crucial challenge in daily clinical practice for accurate disease management; disease activity generally refers to reversible manifestations,while damage refers to irreversible manifestations that are unlikely to benefit from treatment escalation.